Immix Biopharma, Inc. (IMMX)

CIK 1873835 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Immix Biopharma, Inc..

Recent SEC filings

FiledFormAccession number
Oct 27, 2026SCHEDULE 13G0002012383-26-003795
Sep 30, 20268-K0001493152-26-045143
Sep 29, 20268-K0001493152-26-044761
Sep 29, 2026424B50001493152-26-044771
Sep 29, 2026FWP0001493152-26-044774
Aug 14, 2026SCHEDULE 13G0001580642-26-005295
Aug 13, 2026SCHEDULE 13G/A0001274173-26-000202
Aug 7, 202610-Q0001493152-26-036643
Jul 20, 20268-K0001493152-26-033829
Jun 5, 2026SCHEDULE 13G/A0001274173-26-000156
May 29, 202640001493152-26-026428
May 29, 202640001493152-26-026422
May 29, 202640001493152-26-026423
May 29, 20268-K0001493152-26-026431
May 29, 202640001493152-26-026427
May 29, 202640001493152-26-026426
May 29, 202640001493152-26-026425
May 29, 202640001493152-26-026424
May 29, 202640001493152-26-026429
May 29, 202640001493152-26-026430
May 21, 20268-K0001493152-26-024707
May 21, 2026FWP0001493152-26-024715
May 21, 20268-K0001493152-26-024872
May 21, 2026424B50001493152-26-024869
May 15, 2026SCHEDULE 13G/A0001274173-26-000146